NASDAQ · CLOV
Healthcare · Medical - Healthcare Plans
$4.66
Down-$0.44 (-8.63%)
Updated Sep 16, 2026, 11:12 AM
SID Score
6.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CLOV closed at $4.66 after 20 trading sessions, up 10.17% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $5.06 | $5.0964 | $4.59 | $4.66 | 9.66M |
| Sep 14, 2026 | $4.82 | $5.185 | $4.82 | $5.10 | 5.49M |
| Sep 11, 2026 | $4.75 | $4.84 | $4.65 | $4.82 | 4.49M |
| Sep 10, 2026 | $4.48 | $4.77 | $4.46 | $4.71 | 6.71M |
| Sep 9, 2026 | $4.27 | $4.36 | $4.13 | $4.34 | 4.4M |
| Sep 8, 2026 | $4.23 | $4.335 | $4.12 | $4.29 | 3.05M |
| Sep 4, 2026 | $4.23 | $4.285 | $4.22 | $4.255 | 2.07M |
| Sep 3, 2026 | $4.34 | $4.3695 | $4.22 | $4.255 | 2.95M |
| Sep 2, 2026 | $4.295 | $4.365 | $4.225 | $4.30 | 3.32M |
| Sep 1, 2026 | $4.16 | $4.355 | $4.16 | $4.30 | 3.56M |
| Aug 31, 2026 | $4.21 | $4.25 | $4.14 | $4.15 | 3.6M |
| Aug 28, 2026 | $4.18 | $4.29 | $4.17 | $4.23 | 4.18M |
| Aug 27, 2026 | $4.32 | $4.3453 | $4.225 | $4.23 | 3.38M |
| Aug 26, 2026 | $4.10 | $4.3131 | $4.10 | $4.25 | 3.2M |
| Aug 25, 2026 | $4.16 | $4.19 | $4.035 | $4.13 | 2.71M |
| Aug 24, 2026 | $4.15 | $4.18 | $4.08 | $4.11 | 2.76M |
| Aug 21, 2026 | $4.14 | $4.18 | $4.085 | $4.15 | 2.72M |
| Aug 20, 2026 | $4.18 | $4.26 | $4.095 | $4.10 | 3.91M |
| Aug 19, 2026 | $4.29 | $4.37 | $4.16 | $4.22 | 2.88M |
| Aug 18, 2026 | $4.24 | $4.35 | $4.20 | $4.23 | 3.43M |
The latest Smart Investors Daily articles mentioning CLOV.
CLOV research
Company profile and research snapshot.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 6, 2026 | UBS | Neutral | — |
| Jul 21, 2026 | Canaccord Genuity | Buy | — |
| Jun 11, 2026 | UBS | Neutral | — |
| Jun 4, 2026 | Canaccord Genuity | Buy | — |
| Mar 20, 2026 | Canaccord Genuity | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 11, 2026
Clover Health Investments (NASDAQ:CLOV) grew its share price by 8.53 percent on Thursday to finish at $4.71 apiece, as investors took heart from Deutsche Bank’s optimistic rating for its stock. In its initial coverage of the stock, the investment firm assigned a buy recommendation on shares of Clover Health Investments (NASDAQ:CLOV) alongside a price target […]
Yahoo · Sep 11, 2026
Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 8.5% in the afternoon session after Deutsche Bank initiated coverage on the company with a Buy rating and a $6.00 price target.
Benzinga · Sep 10, 2026
U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
Yahoo · Sep 3, 2026
Global services sectors are still growing, and employment is holding up in many major economies, even as costs remain a concern. That mix of resilience and pressure keeps investors hunting for lower priced stocks that still have enough cash to fund their plans. This article highlights three cash backed penny stocks from our premium low price screener that aim to give you early stage exposure with fewer balance sheet red flags. The stocks in the list below are just a starting sample, and the...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CLOV.
